Aigen Investment Management, LP Uro Gen Pharma Ltd. Transaction History

Aigen Investment Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$17.54 - $25.43 $187,888 - $272,406	-10,712 Closed	0 $0
Q3 2020 Nov 06, 2020	SELL	$18.81 - $26.42 $714 - $1,003	-38 Reduced 0.35%	10,712 $207,000
Q2 2020 Aug 10, 2020	BUY	$16.5 - $29.7 $37,026 - $66,646	2,244 Added 26.38%	10,750 $281,000
Q1 2020 May 08, 2020	BUY	$13.68 - $34.6 $99,563 - $251,818	7,278 Added 592.67%	8,506 $152,000
Q4 2019 Feb 04, 2020	BUY	$21.11 - $34.86 $25,923 - $42,808	1,228 New	1,228 $41,000

120

39.3M

158K

161K

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $282M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.